TEVETEN HCT Drug Patent Profile

Which patents cover Teveten Hct, and when can generic versions of Teveten Hct launch?

Teveten Hct is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in TEVETEN HCT is eprosartan mesylate; hydrochlorothiazide. There are eleven drug master file entries for this compound. Additional details are available on the eprosartan mesylate; hydrochlorothiazide profile page.

Summary for TEVETEN HCT

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	2
Clinical Trials:	3
Patent Applications:	8
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in TEVETEN HCT?	TEVETEN HCT excipients list
DailyMed Link:	TEVETEN HCT at DailyMed

Recent Clinical Trials for TEVETEN HCT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Abbott	Phase 3
author! et al. BV	Phase 3
Synexus	Phase 3

See all TEVETEN HCT clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for TEVETEN HCT

C03AA	Thiazides, plain
C03A	LOW-CEILING DIURETICS, THIAZIDES
C03	DIURETICS
C	Cardiovascular system

C09CA	Angiotensin II receptor blockers (ARBs), plain
C09C	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for TEVETEN HCT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	TABLET;ORAL	021268-001	Nov 1, 2001		DISCN	No	No
Abbvie	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	TABLET;ORAL	021268-002	Nov 1, 2001		DISCN	No	No

Expired US Patents for TEVETEN HCT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	TABLET;ORAL	021268-002	Nov 1, 2001
Abbvie	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	TABLET;ORAL	021268-001	Nov 1, 2001
Abbvie	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	TABLET;ORAL	021268-002	Nov 1, 2001
Abbvie	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	TABLET;ORAL	021268-001	Nov 1, 2001

International Patents for TEVETEN HCT

See the table below for patents covering TEVETEN HCT around the world.

Country	Patent Number	Title	Estimated Expiration
Israel	94698	Imidazolyl-alkenoic acids and amides, process for their preparation and pharmaceutical compositions containing them
Czech Republic	281635	Methansulfonát kyseliny (E)-3-/2-n-butyl-1-/(4-karboxyfenyl)-methyl/-1H-imidazol-5-yl/-2-(2-thienyl)methyl-2-propenové, způsob jeho výroby a farmaceutické prostředky s jeho obsahem (METHANESULFONATE OF (E)-3-/2-n-BUTYL-1-/(4-CARBOPHENYL)-METHYL /-1H -IMIDAZOL-5-YL/-2-(2-THIENYL)METHYL-2-PROPENOIC ACID, PROCESS OF ITS PREPARATION AND PHARMACEUTICAL PREPARATIONS IN WHICH IT IS COMPRISED)
Japan	3398379
Norway	902632
Canada	2098176	COMPOSITIONS INHIBITRICES DES RECEPTEURS DE L'ANGIOTENSINE II (ANGIOTENSIN II RECEPTOR BLOCKING COMPOSITIONS)
European Patent Office	0955294	Acides imidazoalcénoiques (Imidazolyl-alkenoic acid)
African Regional IP Organization (ARIPO)	527	The methanesulfonate salt of (E)-3-(2-n-butyl-1-((4-carboxypenyl) methyl) -1H- imidazol-5-yl)-2-(thienyl)methyl-2-propenoic acid and pharmaceutical compositions containing this compound.

Supplementary Protection Certificates for TEVETEN HCT

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0403159	14/2000	Austria		PRODUCT NAME: EPROSARTAN, AUCH IN FORM PHARMAZEUTISCH VERTRAEGLICHER SALZE WIE EPROSARTAN MESYLAT; NAT. REGISTRATION NO/DATE: 1-22115, 1-22114, 1-22117 19970930; FIRST REGISTRATION: DE 39573.00.00 - 39573.02.00 19970417
0403159	C300006	Netherlands		PRODUCT NAME: EPROSARTAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET MESYLAAT; NAT. REGISTRATION NO/DATE: RVG 22258 - RVG 22260 19980106; FIRST REGISTRATION: DE 39573.00.00 - 39573.00.00 19970417
0565634	91234	Luxembourg		91234, EXPIRES: 20161213
0565634	300115	Netherlands
0565634	C300115	Netherlands		PRODUCT NAME: EPROSARTANUM DESGEWENST IN DE VORM VAN EEN; NAT. REGISTRATION NO/DATE: RVG 25926 20020905; FIRST REGISTRATION: RVG 25926 20020905
0403159	SPC/GB00/010	United Kingdom		PRODUCT NAME: EPROSARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT INCLUDING EPROSARTAN MESYLATE; REGISTERED: DE 39 573.00.00 19970417; DE 39 573.01.00 19970417; DE 39 573.02.00 19970417; UK PL00512/0162 19990823; UK PL00512/0163 19990823; UK PL00512/0164 19990823
0565634	06C0030	France		PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607